Patents Assigned to Daesang Corporation
  • Publication number: 20240068000
    Abstract: The present invention relates to an E. coli hisG-derived ATP-phosphoribosyltransferase variant having a reduced feedback inhibition by histidine and a strain expressing the same. The variant may maintain its activity even at a high histidine concentration, thus increasing histidine production.
    Type: Application
    Filed: April 26, 2021
    Publication date: February 29, 2024
    Applicant: DAESANG CORPORATION
    Inventors: Jong Yun HAN, Chel Min YANG, Yong Soo KIM, Young Il JO
  • Publication number: 20240060103
    Abstract: The present invention relates to an E. coli hisG-derived ATP-phosphoribosyltransferase variant having a reduced feedback inhibition by histidine and a strain expressing the same. The variant may maintain its activity even at a high histidine concentration, thus increasing histidine production.
    Type: Application
    Filed: April 26, 2021
    Publication date: February 22, 2024
    Applicant: DAESANG CORPORATION
    Inventors: Jong Yun HAN, Chel Min YANG, Yong Soo KIM, Young Il JO
  • Publication number: 20240060104
    Abstract: The present invention relates to an E. coli hisG-derived ATP-phosphoribosyltransferase variant having a reduced feedback inhibition by histidine and a strain expressing the same. The variant may maintain its activity even at a high histidine concentration, thus increasing histidine production.
    Type: Application
    Filed: April 26, 2021
    Publication date: February 22, 2024
    Applicant: DAESANG CORPORATION
    Inventors: Jong Yun HAN, Chel Min YANG, Yong Soo KIM, Young Il JO
  • Publication number: 20240060057
    Abstract: The present invention relates to an E. coli hisG-derived ATP-phosphoribosyltransferase variant having a reduced feedback inhibition by histidine and a strain expressing the same. The variant may maintain its activity even at a high histidine concentration, thus increasing histidine production.
    Type: Application
    Filed: April 26, 2021
    Publication date: February 22, 2024
    Applicant: DAESANG CORPORATION
    Inventors: Jong Yun HAN, Chel Min YANG, Yong Soo KIM, Young Il JO
  • Publication number: 20240052389
    Abstract: The present invention provides a novel allulose epimerase variant in which an amino acid residue present at a specific position of an amino acid sequence of wild-type D-allulose 3-epimerase derived from Flavonifractor plautii is substituted with another amino acid residue, and various uses thereof. The novel allulose epimerase variant according to the present invention has a higher conversion activity of fructose to allulose than that of the wild-type D-allulose 3-epimerase derived from Flavonifractor plautii or a D-allulose epimerase variant W29K/G216S/M234I, and has excellent thermal stability especially under high temperature conditions of 60° C. or higher, thereby preventing contamination during an industrial-scale enzymatic conversion reaction for the mass production of allulose, shortening the production time, and reducing the production costs.
    Type: Application
    Filed: November 22, 2021
    Publication date: February 15, 2024
    Applicant: DAESANG CORPORATION
    Inventors: Ji Ha LEE, Tae Gyun KIM, Baek Joong KIM, Da Han JUNG, Seung Woo CHO, Hak Jun KIM
  • Publication number: 20240043885
    Abstract: Disclosed is a mutant strain having improved aromatic amino acid production capability as a result of the inactivation or weakening of activity of asparaginase which is expressed by ansB gene.
    Type: Application
    Filed: October 19, 2023
    Publication date: February 8, 2024
    Applicant: DAESANG CORPORATION
    Inventors: Won Joo SHIN, Young II Jo, Sun Hee Lee, Hyun Young Kim, Yong Soo Kim, Cheol Min Yang
  • Publication number: 20240026282
    Abstract: The present disclosure relates to a Corynebacterium sp. mutant strain having increased L-arginine or L-citrulline productivity and a method of producing L-arginine or L-citrulline using the same. The Corynebacterium sp. mutant strain has enhanced activity of acetylglutamate kinase involved in the L-arginine biosynthesis pathway, and thus is capable of producing L-arginine or L-citrulline in an increased yield compared to a parent strain.
    Type: Application
    Filed: October 4, 2022
    Publication date: January 25, 2024
    Applicant: DAESANG CORPORATION
    Inventors: Mi RYU, Sun Jun Yoon, In Pyo Hong, Seok Hyun Park
  • Publication number: 20240026283
    Abstract: The present disclosure relates to a Corynebacterium sp. mutant strain having increased L-arginine or L-citrulline productivity and a method of producing L-arginine or L-citrulline using the same. The Corynebacterium sp. mutant strain has enhanced activity of acetylornithine aminotransferase involved in the L-arginine biosynthesis pathway, and thus is capable of producing L-arginine or L-citrulline productivity in an increased yield compared to a parent strain.
    Type: Application
    Filed: October 4, 2022
    Publication date: January 25, 2024
    Applicant: DAESANG CORPORATION
    Inventors: Mi RYU, Sun Jun YOON, In Pyo HONG, Seok Hyun PARK
  • Publication number: 20230332192
    Abstract: The present invention relates to a Corynebacterium glutamicum mutant strain having increased L-citrulline productivity and a method of producing L-citrulline using the same. The Corynebacterium glutamicum mutant strain is capable of producing L-citrulline in high yield and high concentration because the activity of the transport protein that is expressed by the NCgl2816 gene therein has been weakened or inactivated.
    Type: Application
    Filed: March 23, 2021
    Publication date: October 19, 2023
    Applicant: DAESANG CORPORATION
    Inventors: Dong Seok LEE, Min Jin CHOI, Moon Jeong KIM, Seok Hyun PARK, Jae Chun HAN
  • Publication number: 20230313244
    Abstract: The present disclosure relates to a Corynebacterium glutamicum mutant strain having enhanced L-lysine productivity and a method of producing L-lysine using the same. The Corynebacterium glutamicum mutant strain may produce L-lysine in an improved yield by inhibiting the conversion of oxaloacetate to citrate due to decreased or inhibited expression of the gene encoding the citrate synthase.
    Type: Application
    Filed: April 20, 2021
    Publication date: October 5, 2023
    Applicant: DAESANG CORPORATION
    Inventors: Mi RYU, In Pyo HONG, Min Jin CHOI, Seok Hyun PARK, Jae Chun HAN
  • Publication number: 20230309582
    Abstract: Provided are a beverage composition comprising: chlorophyll-deficient Chlorella; a specific gum as a stabilizer; and an aqueous liquid medium and a process for preparing the same, wherein the beverage composition exhibits excellent dispersion stability without precipitation, and prevent the browning phenomenon occurring in a sterilization process.
    Type: Application
    Filed: August 25, 2021
    Publication date: October 5, 2023
    Applicant: DAESANG CORPORATION
    Inventors: Bo-Ra KIM, Ji-Eun HWANG, Jin-Young JEON
  • Publication number: 20230248031
    Abstract: A composition for preparing a protein-containing noodle containing a vegetable raw material and a method for preparing a protein-containing noodle using the same are disclosed. The composition for preparing a protein-containing noodle contains vegetable proteins, potato fibers, alginate, and starch. According to embodiments, low-calorie, high-protein-containing noodles with high protein content and excellent flavor may be prepared by using vegetable protein as the main raw material for noodles, and the mouthfeel and textural properties of the noodles may be greatly improved by using the vegetable proteins in combination with potato fibers, alginate, and starch. In addition, the raw material pretreatment and noodle making process are simplified, and thus, noodles may be prepared in a simple way and may be applied to mass production.
    Type: Application
    Filed: October 13, 2021
    Publication date: August 10, 2023
    Applicant: DAESANG CORPORATION
    Inventors: Yong Gun KIM, Myung Hee BYUN, Joong Hyun JIN, Doo Hyun AN, Yu Hwan KIM
  • Publication number: 20230220430
    Abstract: The present invention relates to a strain which has increased glutamine productivity due to being transformed with a vector containing a nucleotide sequence that encodes a glutamine synthetase consisting of the amino acid sequence of SEQ ID NO: 1.
    Type: Application
    Filed: March 24, 2021
    Publication date: July 13, 2023
    Applicant: DAESANG CORPORATION
    Inventors: In Pyo HONG, Bong Ki KIM, Min Jin CHOI, Seok Hyun PARK, Jae Chun HAN
  • Publication number: 20230220429
    Abstract: The present invention relates to a method of producing a flavor by a co-fermentation process using mixed fermentation of two or more different microorganisms producing different products. The method of producing a flavor may produce a natural flavor capable of improving the taste and aroma of food and the overall sensory properties of food through a fermentation broth containing amino acids, nucleic acids and/or organic acids, which is produced by mixed fermentation of different microorganisms producing different products, that is, different kinds of amino acids, nucleic acids and/or organic acids. This flavor may be used in various food fields.
    Type: Application
    Filed: July 14, 2022
    Publication date: July 13, 2023
    Applicant: DAESANG CORPORATION
    Inventors: Hyun Ho KIM, Sun Hee LEE, Dong Hyun KIM, Hyun Sook KIM, Seok Hyun PARK, Joon Hyun PARK
  • Publication number: 20230136217
    Abstract: The present invention relates to a Corynebacterium glutamicum mutant strain having increased L-glutamic acid productivity, a method for constructing the same, and a method of producing L-glutamic acid using the same. The Corynebacterium glutamicum mutant strain is a strain into which a mechanosensitive ion channel gene derived from a Corynebacterium sp. strain has been introduced, and thus it can produce L-glutamic acid in an improved yield due to enhancement of glutamic acid release. Therefore, when the mutant strain is used, it is possible to more effectively produce L-glutamic acid.
    Type: Application
    Filed: August 26, 2020
    Publication date: May 4, 2023
    Applicant: DAESANG CORPORATION
    Inventors: Young Ju LEE, Bong Ki KIM, Min Jin CHOI, Seok Hyun PARK, Jae Chun HAN
  • Patent number: 11634740
    Abstract: The present invention provides: a novel allulose epimerase variant in which an amino acid residue present at a specific position of an amino acid sequence of a wild-type D-allulose 3-epimerase derived from Flavonifractor plautii is substituted with another amino acid residue; and various uses of the novel allulose epimerase variant. The novel allulose epimerase variant according to the present invention has a higher conversion rate of fructose to allulose compared to that of the wild-type D-allulose 3-epimerase derived from Flavonifractor plautii, and has excellent thermal stability especially under high temperature conditions of 60° C. or higher, and thus can prevent contamination during an industrial-scale enzymatic conversion reaction for the mass production of allulose, shorten production time, and reduce production costs.
    Type: Grant
    Filed: April 27, 2021
    Date of Patent: April 25, 2023
    Assignee: DAESANG CORPORATION
    Inventors: Hyung Seop Youn, Eun Seok Choi, Ji Ha Lee, Suok Su Kim, Seung Woo Cho, Tae Yong Kim, Hak Jun Kim
  • Publication number: 20230055400
    Abstract: The present invention provides: a novel allulose epimerase variant in which an amino acid residue present at a specific position of an amino acid sequence of a wild-type D-allulose 3-epimerase derived from Flavonifractor plautii is substituted with another amino acid residue; and various uses of the novel allulose epimerase variant. The novel allulose epimerase variant according to the present invention has a higher conversion rate of fructose to allulose compared to that of the wild-type D-allulose 3-epimerase derived from Flavonifractor plautii, and has excellent thermal stability especially under high temperature conditions of 60° C. or higher, and thus can prevent contamination during an industrial-scale enzymatic conversion reaction for the mass production of allulose, shorten production time, and reduce production costs.
    Type: Application
    Filed: April 27, 2021
    Publication date: February 23, 2023
    Applicant: DAESANG CORPORATION
    Inventors: Hyung Seop YOUN, Eun Seok CHOI, Ji Ha LEE, Suok Su KIM, Seung Woo CHO, Tae Yong KIM, Hak Jun KIM
  • Publication number: 20230050643
    Abstract: Provided is a mutant strain having improved aromatic amino acid production capability as a result of inactivation or weakening of activity of glutaminase which is expressed by glutaminase B (glsB) gene.
    Type: Application
    Filed: June 26, 2020
    Publication date: February 16, 2023
    Applicant: DAESANG CORPORATION
    Inventors: Won Joo SHIN, Young Il JO, Sun Hee LEE, Hyun Young KIM, Yong Soo KIM, Cheol Min YANG
  • Publication number: 20220411834
    Abstract: Disclosed is a mutant strain having improved aromatic amino acid production capability due to inactivation or weakening of activity of an FMN/FAD exporter protein which is expressed by yeeO gene.
    Type: Application
    Filed: June 26, 2020
    Publication date: December 29, 2022
    Applicant: DAESANG CORPORATION
    Inventors: Won Joo SHIN, Young Il JO, Sun Hee LEE, Hyun Young KIM, Yong Soo KIM, Cheol Min YANG
  • Publication number: 20220372532
    Abstract: Disclosed is a mutant strain having improved aromatic amino acid production capability as a result of the inactivation or weakening of activity of asparaginase which is expressed by ansB gene.
    Type: Application
    Filed: June 26, 2020
    Publication date: November 24, 2022
    Applicant: DAESANG CORPORATION
    Inventors: Won Joo SHIN, Young Il JO, Sun Hee LEE, Hyun Young KIM, Yong Soo KIM, Cheol Min YANG